drugset
drugset / Trial / NCT04461756

Safety and Pharmacokinetics of Vaped Cannabis in Healthy Volunteers

NCT04461756 ↗

Phase 1 Completed 12 enrolled Tetra Bio-Pharma Algorithme Pharma Inc · collab
NaSingle-groupOpen-labelTreatment

Summary

The primary objective of this study was to evaluate the pharmacokinetics (PK) of THC, 11-OH-THC and CBD following a single inhaled dose of PPP001 administered by vaporization. The secondary objective of this study was to determine the safety and tolerability of THC and CBD after a single inhaled dose of PPP001 administered by vaporization in healthy volunteers.

Timeline

Start
2018-11-01
Primary completion
2018-11-24
Completion
2018-11-24

Drugs

EvaluationDrugModalityDoseRoute
Subject PPP001 Traditional medicine (herbal / TCM) — Inhaled

Indications

No indication recorded.